Загрузка...

RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine

BACKGROUND: Gemcitabine has been widely used as a chemotherapeutic drug. However, drug resistance, short half-life and side effects seriously decrease its chemotherapeutic efficacy. PURPOSE: The object of preparing RGDV-gemcitabine was to prolong the half-life, to overcome drug resistance and to eli...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Nanomedicine
Главные авторы: Liu, Wenchao, Mao, Yujia, Zhang, Xiaoyi, Wang, Yaonan, Wu, Jianhui, Zhao, Shurui, Peng, Shiqi, Zhao, Ming
Формат: Artigo
Язык:Inglês
Опубликовано: Dove 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6737205/
https://ncbi.nlm.nih.gov/pubmed/31686807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S212978
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!